Related Experiment Video
Updated: Jun 22, 2026

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
Cholinergic control of inflammation.
1The Feinstein Institute for Medical Research, North Shore-LIJ Health System, Manhasset, NY 11030, USA.
The neural control of inflammation involves the cholinergic anti-inflammatory pathway, using the vagus nerve and acetylcholine. This pathway, dependent on the nicotinic acetylcholine receptor alpha7 subunit, offers therapeutic potential for inflammatory diseases.
Area of Science:
- Neuroimmunology
- Autonomic Nervous System Regulation
- Inflammation Research
Background:
- Cytokine production is vital for immunity and repair but can cause fatal systemic inflammation if excessive.
- The central nervous system modulates immune responses via neural and humoral pathways.
- While humoral mediators of inflammation are well-studied, neural control is a recent focus.
Purpose of the Study:
- To review the autonomic regulation of inflammation via the cholinergic anti-inflammatory pathway.
- To explore the role of acetylcholine and its receptors in modulating inflammatory responses.
- To discuss therapeutic applications for inflammatory conditions.
Main Methods:
- Literature review summarizing research on the cholinergic anti-inflammatory pathway.
- Analysis of the vagus nerve's role in inflammation.
- Examination of acetylcholine sources, nicotinic acetylcholine receptor alpha7 subunit function, and acetylcholinesterase regulation.
Main Results:
- The vagus nerve and acetylcholine constitute the cholinergic anti-inflammatory pathway.
- Nicotinic acetylcholine receptor alpha7 subunit is crucial for this anti-inflammatory mechanism.
- Acetylcholine regulation by acetylcholinesterase serves to attenuate inflammation.
Conclusions:
- The cholinergic anti-inflammatory pathway represents a key neural mechanism for controlling inflammation.
- Targeting this pathway holds promise for treating acute and chronic inflammatory diseases, including autoimmune disorders.
- Further research is needed to fully elucidate and exploit this pathway therapeutically.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Parasympathetic Signaling
The effects of...
Cholinergic Receptors: Muscarinic
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...

